La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation

Identifieur interne : 003383 ( Main/Exploration ); précédent : 003382; suivant : 003384

Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation

Auteurs : Christopher J. D Sinclair [Canada] ; P. Nicholas Shepel [Canada] ; Jonathan D. Geiger [Canada] ; Fiona E. Parkinson [Canada]

Source :

RBID : ISTEX:4FC2ADCBA661D4DD95133E0A6442C2B02E2DE317

English descriptors

Abstract

Adenosine is produced intracellularly during conditions of metabolic stress and is an endogenous agonist for four subtypes of G-protein linked receptors. Nucleoside transporters are membrane-bound carrier proteins that transfer adenosine, and other nucleosides, across biological membranes. We investigated whether adenosine receptor activation could modulate transporter-mediated adenosine efflux from metabolically stressed cells. DDT1 MF-2 smooth muscle cells were incubated with 10 μM [3H]adenine to label adenine nucleotide pools. Metabolic stress with the glycolytic inhibitor iodoacetic acid (IAA, 5 mM) increased tritium release by 63% (P < 0.01), relative to cells treated with buffer alone. The IAA-induced increase was blocked by the nucleoside transport inhibitor nitrobenzylthioinosine (1 μM), indicating that the increased tritium release was primarily a purine nucleoside. HPLC verified this to be [3H]adenosine. The adenosine A1 receptor selective agonist N6-cyclohexyladenosine (CHA, 300 nM) increased the release of [3H]purine nucleoside induced by IAA treatment by 39% (P < 0.05). This increase was blocked by the A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (10 μM). Treatment of cells with UTP (100 μM), histamine (100 μM), or phorbol-12-myristate-13-acetate (PMA, 10 μM) also increased [3H]purine nucleoside release. The protein kinase C inhibitor chelerythrine chloride (500 nM) inhibited the increase in [3H]purine nucleoside efflux induced by CHA or PMA treatment. The adenosine kinase activity of cells treated with CHA or PMA was found to be decreased significantly compared with buffer-treated cells. These data indicated that adenosine A1 receptor activation increased nucleoside efflux from metabolically stressed DDT1 MF-2 cells by a PKC-dependent inhibition of adenosine kinase activity.

Url:
DOI: 10.1016/S0006-2952(99)00350-0


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="no">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation</title>
<author>
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D" last="Sinclair">Christopher J. D Sinclair</name>
</author>
<author>
<name sortKey="Shepel, P Nicholas" sort="Shepel, P Nicholas" uniqKey="Shepel P" first="P. Nicholas" last="Shepel">P. Nicholas Shepel</name>
</author>
<author>
<name sortKey="Geiger, Jonathan D" sort="Geiger, Jonathan D" uniqKey="Geiger J" first="Jonathan D" last="Geiger">Jonathan D. Geiger</name>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4FC2ADCBA661D4DD95133E0A6442C2B02E2DE317</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0006-2952(99)00350-0</idno>
<idno type="url">https://api-v5.istex.fr/document/4FC2ADCBA661D4DD95133E0A6442C2B02E2DE317/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000304</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000304</idno>
<idno type="wicri:Area/Istex/Curation">000304</idno>
<idno type="wicri:Area/Istex/Checkpoint">001103</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001103</idno>
<idno type="wicri:doubleKey">0006-2952:2000:Sinclair C:stimulation:of:nucleoside</idno>
<idno type="wicri:Area/Main/Merge">003911</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10660114</idno>
<idno type="wicri:Area/PubMed/Corpus">001655</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001655</idno>
<idno type="wicri:Area/PubMed/Curation">001655</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001655</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001655</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001655</idno>
<idno type="wicri:Area/Ncbi/Merge">000071</idno>
<idno type="wicri:Area/Ncbi/Curation">000071</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000071</idno>
<idno type="wicri:doubleKey">0006-2952:2000:Sinclair C:stimulation:of:nucleoside</idno>
<idno type="wicri:Area/Main/Merge">003856</idno>
<idno type="wicri:Area/Main/Curation">003383</idno>
<idno type="wicri:Area/Main/Exploration">003383</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<author>
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D" last="Sinclair">Christopher J. D Sinclair</name>
<affiliation wicri:level="4">
<country>Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shepel, P Nicholas" sort="Shepel, P Nicholas" uniqKey="Shepel P" first="P. Nicholas" last="Shepel">P. Nicholas Shepel</name>
<affiliation wicri:level="4">
<country>Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Geiger, Jonathan D" sort="Geiger, Jonathan D" uniqKey="Geiger J" first="Jonathan D" last="Geiger">Jonathan D. Geiger</name>
<affiliation wicri:level="4">
<country>Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="1">
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="4">
<country>Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<idno type="ISSN">0006-2952</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-2952</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine (metabolism)</term>
<term>Adenosine Kinase (antagonists & inhibitors)</term>
<term>Animals</term>
<term>Biological Transport</term>
<term>Carrier Proteins (metabolism)</term>
<term>Cricetinae</term>
<term>Membrane Proteins (metabolism)</term>
<term>Nucleoside Transport Proteins</term>
<term>Receptors, Purinergic P1 (metabolism)</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Adenosine Kinase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adenosine</term>
<term>Carrier Proteins</term>
<term>Membrane Proteins</term>
<term>Receptors, Purinergic P1</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Biological Transport</term>
<term>Cricetinae</term>
<term>Nucleoside Transport Proteins</term>
<term>Tumor Cells, Cultured</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Adenosine is produced intracellularly during conditions of metabolic stress and is an endogenous agonist for four subtypes of G-protein linked receptors. Nucleoside transporters are membrane-bound carrier proteins that transfer adenosine, and other nucleosides, across biological membranes. We investigated whether adenosine receptor activation could modulate transporter-mediated adenosine efflux from metabolically stressed cells. DDT1 MF-2 smooth muscle cells were incubated with 10 μM [3H]adenine to label adenine nucleotide pools. Metabolic stress with the glycolytic inhibitor iodoacetic acid (IAA, 5 mM) increased tritium release by 63% (P < 0.01), relative to cells treated with buffer alone. The IAA-induced increase was blocked by the nucleoside transport inhibitor nitrobenzylthioinosine (1 μM), indicating that the increased tritium release was primarily a purine nucleoside. HPLC verified this to be [3H]adenosine. The adenosine A1 receptor selective agonist N6-cyclohexyladenosine (CHA, 300 nM) increased the release of [3H]purine nucleoside induced by IAA treatment by 39% (P < 0.05). This increase was blocked by the A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (10 μM). Treatment of cells with UTP (100 μM), histamine (100 μM), or phorbol-12-myristate-13-acetate (PMA, 10 μM) also increased [3H]purine nucleoside release. The protein kinase C inhibitor chelerythrine chloride (500 nM) inhibited the increase in [3H]purine nucleoside efflux induced by CHA or PMA treatment. The adenosine kinase activity of cells treated with CHA or PMA was found to be decreased significantly compared with buffer-treated cells. These data indicated that adenosine A1 receptor activation increased nucleoside efflux from metabolically stressed DDT1 MF-2 cells by a PKC-dependent inhibition of adenosine kinase activity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Manitoba</li>
</region>
<settlement>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D" last="Sinclair">Christopher J. D Sinclair</name>
</region>
<name sortKey="Geiger, Jonathan D" sort="Geiger, Jonathan D" uniqKey="Geiger J" first="Jonathan D" last="Geiger">Jonathan D. Geiger</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Shepel, P Nicholas" sort="Shepel, P Nicholas" uniqKey="Shepel P" first="P. Nicholas" last="Shepel">P. Nicholas Shepel</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003383 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003383 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4FC2ADCBA661D4DD95133E0A6442C2B02E2DE317
   |texte=   Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022